Remnant Lipoprotein

Lipoprotein particles are responsible for key steps in plaque formation and the development of cardiovascular disease. The LPP Plus test measures 12 lipoprotein particle markers to determine cardiovascular disease risk. This test is not recommended for patients under 18 years of age.

Whether you are at high risk of heart disease, managing an existing diabetic condition, or using GLP-1 drugs sold under brand names of (Ozempic, Wegovy, Mounjaro, Zepbound) or their generics (Semaglutide or Tirzepatide) for diabetes or weight loss, the Cardi-A1c panel is both appropriate and recommended. This panel is specifically designed to monitor the benefits of GLP-1 usage in reducing A1c levels and preventing cardiovascular events such as heart attack, stroke, or death.

The Baseline Nexus combines the Micronutrient Test, LPP Plus, MTHFR, and Telomere tests. Establishing a baseline for cellular micronutrient deficiencies, lipoprotein particles, MTHFR gene mutations, and telomere lengths is essential for understanding an individual’s overall health and risk factors for chronic diseases. A baseline assessment provides critical insights into nutrient imbalances, cardiovascular risks, genetic predispositions, and cellular aging. This information allows for personalized interventions, early detection of potential health issues, and the ability to track progress over time, ultimately supporting proactive and preventative healthcare strategies.

SpectraCell's Cardiac Nexus profile combines their advanced LPP® technology with an MTHFR gene test. LPP® (Lipoprotein Particle Profile) reports the size and type of your lipoproteins, which is recognized as a superior tool in diagnosing problems of cholesterol and lipid metabolism. The patented LPP® test addresses two key issue in heart health missed by other technologies: (1) who is at higher cardiovascular risk and (2) what to do about it. The MTHFR test determines which copy of the MTHFR gene you carry. This gene controls a key enzyme (called Methylenetetrahydrofolate Reductase, or MTHFR). If you carry certain copies of this gene, you may be predisposed to specific B vitamin deficiencies, which overwhelming evidence confirms, is intimately linked to methylation disruptions that impact cardiovascular, neurological, reproductive, and detoxification systems.